|
Mibefradil
|
D02.455.426.559.847.638.960.585 |
|
|
Syphilis
|
C01.221.812.281.859 |
|
|
Proto-Oncogene Proteins c-pim-1
|
D08.811.913.696.620.682.700.776 |
|
|
Drug Partial Agonism
|
G07.690.773.968.154.500 |
|
|
Drug Agonism
|
G07.690.773.968.154 |
|
|
Binomial Distribution
|
G17.820.250 |
|
|
Pyrroloiminoquinones
|
D02.806.400.500 |
|
|
Indolequinones
|
D02.806.400 |
|
|
Anticoagulants
|
D27.505.954.502.119 |
|
|
Hematologic Agents
|
D27.505.954.502 |
|
|
Varenicline
|
D03.633.100.079.900 |
|
|
Benzazepines
|
D03.633.100.079 |
|
|
Chemistry, Physical
|
H01.181.529 |
|
|
Netrin-1
|
D12.776.860.300.731.500 |
|
|
Netrins
|
D12.776.860.300.731 |
|
|
Minichromosome Maintenance Complex Component 9
|
D08.811.277.040.025.159.186.900 |
|
|
Receptor, Transforming Growth Factor-beta Type II
|
D08.811.913.696.620.682.700.795 |
|
|
Nifuratel
|
D02.640.600.410 |
|
|
Nitrofurans
|
D02.640.600 |
|
|
Receptor, Transforming Growth Factor-beta Type I
|
D08.811.913.696.620.682.700.789 |
|
